valproic acid

(redirected from Depakene)
Also found in: Thesaurus, Medical.

val·pro·ic acid

An anticonvulsive drug, C8H15NaO2, given orally and by injection to treat epilepsy.

valproic acid

1. (Pharmacology) a synthetic crystalline compound, used as an anticonvulsive to treat seizure disorders. Formula C7H15COOH
2. (Chemistry) a synthetic crystalline compound, used as an anticonvulsive to treat seizure disorders. Formula C7H15COOH
[C20: from val(erian) + pro(pyl) + -ic]
valˈproate n
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.valproic acid - anticonvulsant (trade name Depokene) used to prevent some kinds of seizures
anticonvulsant, anticonvulsant drug, antiepileptic, antiepileptic drug - a drug used to treat or prevent convulsions (as in epilepsy)

valproic acid, valproate sodium

(USAN), valproate n ácido valproico, valproato sódico or de sodio, valproato
References in periodicals archive ?
Depakene or Depakote); any medicines that impair or decrease your thinking, concentration, or muscle coordination; birth control pills; medicines used to prevent seizures; or any other carbonic anhydrase inhibitors (e.
Sold under brand names that include Depakene, Depakote and Stavzor, valproic acid is used to smooth out the mood swings of people with manic-depressive disorder and related conditions.
The meta-analysis, presented during a poster session, was funded by Abbott Laboratories, which manufactures different types of valproate (Depakote, Depakene, and Depacon).
Valproic acid/ Simple and complex Depakene [R] absence seizures, complex partial seizures, tonic-clonic seizures, and multiple seizures in combination (21).
As regards products, despite a decline in sales of Durotep, an analgesic for persistent cancer pain due to the ending of a joint sales contract, strong sales were maintained by Allelock, an antiallergic agent, Depakene, an anti-epileptic agent, and Patanol, an antiallergic ophthalmic solution, while sales of Coversyl, an ACE inhibitor for treatment of hypertension, that commenced in April, 2008, also performed well and contributed to growth in sales.
Marketed as Depakene and as Stavzor, valproic acid was approved in 1978 for treating epilepsy.
which manufactures valproic acid derivatives under the brand names Depakote, Depakene, and Depacon.